06.06.24|Viki AuslenderThree years have passed since the IPO of genetic testing company 23andMe and it has faced a nosedive in profits due to public mistrust, a one-time use product, ethical concerns about user data, and security breaches
04.03.18|Lilach BaumerAs part of the pro-bono initiative, the Israel-based company will provide 15,000 free DNA testing kits